The study also shows that CERTL binds to Amyloid Precursor Protein (APP), influencing Aβ aggregation, neurotoxicity, and ceramide levels, opening new research avenues for Alzheimer’s disease and other neurodegenerative disorders. The gene discussed is CERT1; the disease is Alzheimer disease.